Frequently Asked Questions:
| REPORT ATTRIBUTE | DETAILS |
|---|---|
| Historical Period | 2019-2022 |
| Base Year | 2023 |
| Forecast Period | 2024-2032 |
| U.S. Guidewires Market Size 2023 | USD 841.67 million |
| U.S. Guidewires Market, CAGR | 5.40% |
| U.S. Guidewires Market Size 2032 | USD 1,351.16 million |
Market Overview
The U.S. guidewires market is a significant component of the medical device industry, showcasing a dynamic blend of innovation, regulatory challenges, and evolving healthcare demands. Guidewires are essential tools in minimally invasive surgeries, serving as a guide for the placement of larger devices, such as stents or catheters, within the body’s vascular system. The demand for guidewires in the U.S. is driven by the rising prevalence of cardiovascular diseases, peripheral artery diseases, and other medical conditions requiring minimally invasive surgical interventions.
The U.S. guidewire market is forecasted to grow from USD 841.67 million in 2023 to USD 1,351.16 million by 2032, with a compound annual growth rate (CAGR) of 5.40%.
This growth is underpinned by an aging population, technological advancements in guidewire materials and coatings, and an increasing preference for minimally invasive procedures that offer shorter recovery times and lower risk of complications compared to traditional surgeries.
The market is segmented by product type into coronary, peripheral, urology, neurovascular, and gastroenterology guidewires, among others. Among these, the coronary guidewires segment holds the largest market share, attributed to the high volume of coronary interventions performed in the U.S. annually. Peripheral guidewires are also gaining traction, fueled by the growing incidence of peripheral artery diseases.
Innovation is a key driver of the U.S. guidewires market, with manufacturers focusing on developing products that offer enhanced flexibility, steerability, and tip load. Additionally, the incorporation of hydrophilic and hydrophobic coatings to improve navigability and reduce friction is becoming increasingly common. These technological advancements are aimed at improving the efficacy and safety of minimally invasive procedures, thereby improving patient outcomes.
Access crucial information at unmatched prices!
Request your sample report today & start making informed decisions powered by Credence Research Inc.!
Download SampleKey Market Drivers
The U.S. guidewire market is poised for significant expansion in the foreseeable future, propelled by several critical factors:
Increasing Demand for Minimally Invasive Surgeries (MIS)
The shift towards minimally invasive procedures is evident, with these techniques offering considerable advantages over traditional surgeries, such as shorter hospitalizations, faster recovery, and less discomfort. This trend, combined with the growing preference of both patients and healthcare providers for MIS, is expected to elevate the demand for guidewires, crucial instruments in these interventions.
Surge in Chronic Disease Prevalence
The United States is witnessing a rise in chronic conditions, including cardiovascular and peripheral artery diseases (PAD), as well as urological disorders. These health issues often necessitate the use of guidewires for treatment, thereby boosting the market’s growth prospects.
Demographic Shifts towards an Aging Population
As the U.S. population ages, the incidence of chronic diseases that require guidewire-assisted procedures is increasing. This demographic trend is anticipated to significantly contribute to the market’s expansion.
Technological Innovations
The guidewire sector is experiencing continuous innovation, with manufacturers introducing advancements such as improved trackability, better visualization capabilities, and sleeker designs. These technological enhancements are making guidewire-based procedures more effective and are a driving force behind the market’s growth.
Supportive Reimbursement Landscape
In the United States, reimbursement policies are generally conducive to the adoption of guidewire procedures, enhancing patient accessibility. This favorable reimbursement environment is likely to persist, further stimulating market growth.
Key Market Restraints
Despite the promising growth prospects of the U.S. guidewires market, it encounters several notable challenges. A primary constraint is the stringent regulatory framework enforced by the Food and Drug Administration (FDA). The process for medical device approval, guidewires included, can be both lengthy and costly, which may hinder the timely introduction of innovative products into the market. Furthermore, manufacturers are required to comply with strict quality and safety standards. While these standards are critical for ensuring patient safety, they can impose significant operational and financial burdens on companies, especially smaller entities with constrained resources.
Moreover, advanced guidewires, such as those featuring hydrophilic coatings for enhanced navigation, tend to be more expensive than their conventional counterparts. This cost disparity can place a financial strain on healthcare providers and patients, particularly in instances where insurance coverage is either partial or nonexistent. Additionally, in the U.S., the insurance coverage for minimally invasive procedures that utilize guidewires may be limited, and in some cases, guidewires might not be covered at all. This lack of comprehensive insurance support can deter hospitals and clinics from adopting new or advanced guidewire technologies, further restraining market growth.
Market Opportunities
- Expansion into Emerging Therapeutic Areas: The continuous exploration of guidewires in new therapeutic areas, such as neurovascular and gastroenterology interventions, presents significant opportunities for market expansion.
- Customization and Personalization: Developing customizable and patient-specific guidewires using advanced manufacturing techniques like 3D printing could address unique anatomical challenges, opening up new market segments.
- Integration with Digital Technologies: Incorporating sensor technologies and real-time data analytics into guidewires could enhance the precision of interventions and offer new functionalities, such as pressure monitoring and lesion assessment.
- Global Expansion: While this report focuses on the U.S. market, international expansion into developing countries with growing healthcare infrastructures represents a considerable opportunity for guidewire manufacturers.
- Partnerships with Healthcare Providers: Collaborating with hospitals and clinics to develop training programs and educational materials can increase the adoption of advanced guidewires, particularly in complex procedures.
- Sustainability Initiatives: Developing eco-friendly guidewires and recycling programs could appeal to environmentally conscious healthcare providers and patients, differentiating products in a competitive market.
- Regulatory Support for Innovation: Engaging with regulatory bodies to streamline the approval process for innovative guidewires can accelerate market entry and adoption.
Segmentations:
By Type
- Coronary
- Peripheral
- Urology
- Neurovascular
- Gastroenterology
By Application
- Hydrophilic Surgical Guidewires
- Hydrophobic Surgical Guidewires
- Hydrophilic Diagnostic Guidewires
- Hydrophobic Diagnostic Guidewires
- Others
By End-user
- Hospitals
- Ambulatory Surgical Centers
- Catheterization Laboratories
- Specialty Clinics
- Others
By Material
- Nitinol Guidewires
- Stainless Steel Guidewires
- Hybrid Guidewires
- PTFE Guidewires
- Others
By Tip Shape
- J Tip
- Angled Tip
- Straight Tip
Interesting Facts About the Market
- The first use of guidewires in medical procedures dates back to the 1960s, highlighting the long history of innovation in this field.
- Guidewires are now used in over 90% of all minimally invasive cardiovascular procedures in the U.S., underscoring their critical role in modern medicine.
- The development of magnetic guidewires, which can be precisely controlled using external magnetic fields, is one of the latest innovations in the field.
- The U.S. is home to some of the world’s leading medical device companies specializing in guidewire technology, reflecting the country’s leadership in medical innovation.
- The increasing use of artificial intelligence and machine learning in the development of guidewires is set to revolutionize how procedures are planned and executed.
- Guidewires made from nitinol, a nickel-titanium alloy, are gaining popularity due to their unique properties, including shape memory and superelasticity.
- The COVID-19 pandemic temporarily impacted the guidewires market due to the postponement of elective surgeries, highlighting the market’s sensitivity to global health crises.
- A growing trend in the market is the emphasis on patient safety and reducing procedure-related complications, driving demand for advanced guidewire technologies.
- The use of guidewires in pediatric care, although challenging, presents a unique opportunity for innovation and market growth.
- The adoption of guidewires in less invasive procedures aligns with the broader healthcare trend towards reducing hospital stay durations and improving patient recovery times.
Top Leading Players
The U.S. guidewires market is highly competitive, with several key players dominating the scene. These include:
- Boston Scientific Corporation
- Terumo Corporation
- Cardinal Health Inc.
- Cook Medical Inc.
- Johnson & Johnson
- Medtronic PLC
- Teleflex Corporation
- Stryker Corporation
- B. Braun Melsungen AG
- Abbott Laboratories
- Olympus Corporation
- Merit Medical Inc.
- BD Company
These companies are at the forefront of innovation, consistently introducing advanced products and expanding their portfolios through strategic acquisitions and partnerships. Their dominance is supported by strong R&D capabilities, extensive distribution networks, and comprehensive product offerings that cater to a wide range of medical procedures.
Recent Developments:
In April 2021, Boston Scientific Corporation introduced its latest Kinetix guidewire designed for application in percutaneous coronary intervention (PCI) procedures.
In January 2021, Teleflex extended the value of the ErgoPack by introducing comprehensive improvements to critical vascular access products.
Competitive Landscape
The competitive landscape of the U.S. guidewires market is characterized by intense competition, with companies vying for market share through innovation, strategic partnerships, and mergers and acquisitions. Product differentiation, based on technology, usability, and clinical outcomes, is a critical strategy adopted by market leaders. Additionally, companies are increasingly focusing on training and education programs for healthcare professionals to enhance the adoption of their products.
Regional Analysis
The U.S. guidewires market demonstrates significant regional variations in terms of demand, adoption rates, and healthcare infrastructure. Regions with a higher concentration of healthcare facilities, such as the Northeast and West Coast, exhibit stronger demand for guidewires. The market in these regions benefits from the presence of leading hospitals and research institutions, which contribute to higher procedure volumes and the adoption of advanced technologies. However, the Southern and Midwestern regions are catching up, driven by improvements in healthcare infrastructure and increasing awareness of minimally invasive procedures. The regional analysis reveals the importance of localized strategies for market penetration and growth, including tailored product offerings and distribution networks.
Access crucial information at unmatched prices!
Request your sample report today & start making informed decisions powered by Credence Research Inc.!
Download SampleFuture Outlook
- Technological Innovations: Continued advancements in material science and engineering will lead to the development of more sophisticated guidewires, offering improved performance and safety.
- Increased Procedure Volumes: The aging population and rising prevalence of target diseases will drive an increase in minimally invasive surgical procedures, fueling demand for guidewires.
- Personalized Medicine: The trend towards personalized medicine will influence guidewire design, with a focus on customizable solutions to meet individual patient needs.
- Digital Integration: The integration of guidewires with digital technologies, including AI and IoT, will enhance procedural accuracy and outcomes, offering new capabilities such as real-time feedback and navigation assistance.
- Regulatory Evolution: Changes in regulatory policies may streamline the approval process for innovative guidewires, accelerating market introduction and adoption.
- Sustainable Practices: Increased emphasis on sustainability in healthcare will drive the development of eco-friendly guidewires and recycling initiatives.
- Global Expansion: U.S. manufacturers will increasingly look to international markets for growth, adapting products and strategies to meet local healthcare needs and regulations.
- Collaborations and Partnerships: Strategic collaborations between guidewire manufacturers and healthcare providers will enhance product development and adoption, particularly for complex procedures.
- Economic Fluctuations: The market will continue to be influenced by economic factors, including healthcare spending and insurance coverage changes, affecting procedure volumes and equipment purchases.
- Patient-Centric Approaches: The focus on improving patient experiences and outcomes will shape future product developments and market strategies, emphasizing less invasive, more efficient procedures.
Table of Content
Chapter No. 1 :………. Introduction.. 20
1.1.1. Report Description. 20
Purpose of the Report 20
USP & Key Offerings. 20
1.1.2. Key Benefits for Stakeholders. 20
1.1.3. Target Audience. 21
1.1.4. Report Scope 21
1.1.5. Regional Scope 22
Chapter No. 2 :………. Executive Summary. 22
2.1. Guidewire Market Snapshot 23
2.1.1. U.S. Guidewire Market, 2018 – 2032 (K Units) (USD Million) 25
2.2. Insights from Primary Respondents. 25
Chapter No. 3 :………. Geopolitical Crisis Impact Analysis. 27
3.1. Russia-Ukraine and Israel-Palestine War Impacts. 27
Chapter No. 4 :………. Guidewire Market – Industry Analysis. 28
4.1. Introduction 28
4.2. Market Drivers 29
4.2.1. Driving Factor 1 Analysis. 29
4.2.2. Driving Factor 2 Analysis. 30
4.3. Market Restraints. 31
4.3.1. Restraining Factor Analysis. 31
4.4. Market Opportunities. 32
4.4.1. Market Opportunity Analysis. 32
4.5. Porter’s Five Forces Analysis. 33
4.6. Value Chain Analysis. 34
4.7. Buying Criteria 35
Chapter No. 5 :………. Import Export Analysis. 36
5.1. Import Analysis by Region. 36
5.1.1. U.S. Guidewire Market Import Volume/Revenue, By Region, 2018 – 2023. 36
5.2. Export Analysis by Region. 37
5.2.1. U.S. Guidewire Market Export Volume/Revenue, By Region, 2018 – 2023. 37
Chapter No. 6 :………. Demand Supply Analysis. 38
6.1. Demand Analysis by Region. 38
6.1.1. U.S. Guidewire Market Demand Volume/Revenue, By Region, 2018 – 2023. 38
6.2. Supply Analysis by Region. 39
6.2.1. U.S. Guidewire Market Supply Volume/Revenue, By Region, 2018 – 2023. 39
Chapter No. 7 :………. Production Analysis. 40
7.1. Production Analysis by Region. 40
7.1.1. U.S. Guidewire Market Production Volume/Revenue, By Region, 2018 – 2023. 40
7.1.2. U.S. Guidewire Market Production Volume, By Region, 2018 – 2023 (K Units) 41
Chapter No. 8 :………. Price Analysis. 42
8.1. Price Analysis by Region. 42
8.1.1. U.S. Guidewire Market Price, By Region, 2018 – 2023. 42
8.1.2. U.S. Type Market Price, By Region, 2018 – 2023. 42
8.2. Price Analysis by Type. 43
8.2.1. U.S. Guidewire Market Price, By Type, 2018 – 2023. 43
8.2.2. U.S. Type Market Price, By Type, 2018 – 2023. 43
Chapter No. 9 :………. Raw Materials Analysis. 44
9.1. Key Raw Materials and Suppliers. 44
9.2. Key Raw Materials Price Trend. 44
Chapter No. 10 :…….. Manufacturing Cost Analysis. 44
10.1. Manufacturing Cost Analysis. 45
10.2. Manufacturing Process. 45
Chapter No. 11 :…….. Analysis Competitive Landscape. 46
11.1. Company Market Share Analysis – 2023. 46
11.1.1. U.S. Guidewire Market: Company Market Share, by Volume, 2023. 46
11.1.2. U.S. Guidewire Market: Company Market Share, by Revenue, 2023. 47
11.1.3. U.S. Guidewire Market: Top 6 Company Market Share, by Revenue, 2023. 47
11.1.4. U.S. Guidewire Market: Top 3 Company Market Share, by Revenue, 2023. 47
11.2. U.S. Guidewire Market Company Volume Market Share, 2023. 49
11.3. U.S. Guidewire Market Company Revenue Market Share, 2023. 50
11.4. Company Assessment Metrics, 2023. 51
11.4.1. Stars 51
11.4.2. Emerging Leaders. 51
11.4.3. Pervasive Players. 51
11.4.4. Participants 51
11.5. Start-ups /SMEs Assessment Metrics, 2023. 51
11.5.1. Progressive Companies. 51
11.5.2. Responsive Companies. 51
11.5.3. Dynamic Companies. 51
11.5.4. Starting Blocks 51
11.6. Strategic Developments. 52
11.6.1. Acquisitions & Mergers. 52
New Product Launch. 52
Regional Expansion. 52
11.7. Key Players Product Matrix. 53
Chapter No. 12 :…….. PESTEL & Adjacent Market Analysis. 54
12.1. PESTEL 54
12.1.1. Political Factors. 54
12.1.2. Economic Factors. 54
12.1.3. Social Factors 54
12.1.4. Technological Factors. 54
12.1.5. Environmental Factors. 54
12.1.6. Legal Factors 54
12.2. Adjacent Market Analysis. 54
Chapter No. 13 :…….. Guidewire Market – By Type Segment Analysis. 55
13.1. Guidewire Market Overview, by Type Segment 55
13.1.1. Guidewire Market Volume Share, By Type, 2023 & 2032. 56
13.1.2. Guidewire Market Revenue Share, By Type, 2023 & 2032. 56
13.1.3. Guidewire Market Attractiveness Analysis, By Type. 57
13.1.4. Incremental Revenue Growth Opportunity, by Type, 2024 – 2032. 57
13.1.5. Guidewire Market Revenue, By Type, 2018, 2023, 2027 & 2032. 58
13.2. Coronary 59
13.3. Peripheral 60
13.4. Urology 61
13.5. Neurovascular 62
13.6. Gastroenterology. 63
Chapter No. 14 :…….. Guidewire Market – By Application Segment Analysis. 64
14.1. Guidewire Market Overview, by Application Segment 64
14.1.1. Guidewire Market Volume Share, By Application, 2023 & 2032. 65
14.1.2. Guidewire Market Revenue Share, By Application, 2023 & 2032. 65
14.1.3. Guidewire Market Attractiveness Analysis, By Application. 66
14.1.4. Incremental Revenue Growth Opportunity, by Application, 2024 – 2032. 66
14.1.5. Guidewire Market Revenue, By Application, 2018, 2023, 2027 & 2032. 67
14.2. Hydrophilic Surgical Guidewires. 68
14.3. Hydrophobic Surgical Guidewires. 69
14.4. Hydrophilic Diagnostic Guidewires. 70
14.5. Hydrophobic Diagnostic Guidewires. 71
14.6. Others 72
Chapter No. 15 :…….. Guidewire Market – By End-user Segment Analysis. 73
15.1. Guidewire Market Overview, by End-user Segment 73
15.1.1. Guidewire Market Volume Share, By End-user, 2023 & 2032. 74
15.1.2. Guidewire Market Revenue Share, By End-user, 2023 & 2032. 74
15.1.3. Guidewire Market Attractiveness Analysis, By End-user 75
15.1.4. Incremental Revenue Growth Opportunity, by End-user, 2024 – 2032. 75
15.1.5. Guidewire Market Revenue, By End-user, 2018, 2023, 2027 & 2032. 76
15.2. Hospitals 77
15.3. Ambulatory Surgical Centers. 78
15.4. Catheterization Laboratories. 79
15.5. Specialty Clinics. 80
15.6. Others 81
Chapter No. 16 :…….. Guidewire Market – By Material Segment Analysis. 82
16.1. Guidewire Market Overview, by Material Segment 82
16.1.1. Guidewire Market Volume Share, By Material, 2023 & 2032. 83
16.1.2. Guidewire Market Revenue Share, By Material, 2023 & 2032. 83
16.1.3. Guidewire Market Attractiveness Analysis, By Material 84
16.1.4. Incremental Revenue Growth Opportunity, by Material, 2024 – 2032. 84
16.1.5. Guidewire Market Revenue, By Material, 2018, 2023, 2027 & 2032. 85
16.2. Nitinol Guidewires. 86
16.3. Stainless Steel Guidewires. 87
16.4. Hybrid Guidewires. 88
16.5. PTFE Guidewires. 89
16.6. Others 90
Chapter No. 17 :…….. Guidewire Market – By Tip Shape Segment Analysis. 91
17.1. Guidewire Market Overview, by Tip Shape Segment 91
17.1.1. Guidewire Market Volume Share, By Tip Shape, 2023 & 2032. 92
17.1.2. Guidewire Market Revenue Share, By Tip Shape, 2023 & 2032. 92
17.1.3. Guidewire Market Attractiveness Analysis, By Tip Shape. 93
17.1.4. Incremental Revenue Growth Opportunity, by Tip Shape, 2024 – 2032. 93
17.1.5. Guidewire Market Revenue, By Tip Shape, 2018, 2023, 2027 & 2032. 94
17.2. J Tip 95
17.3. Angled Tip 96
17.4. Straight Tip 97
Chapter No. 18 :…….. Company Profiles. 98
18.1. Boston Scientific Corporation. 98
18.1.1. Company Overview.. 98
18.1.2. Product Portfolio. 98
18.1.3. Swot Analysis 98
18.1.4. Business Strategy. 98
18.1.5. Financial Overview.. 99
18.2. Terumo Corporation. 100
18.3. Cardinal Health Inc. 100
18.4. Cook Medical Inc. 100
18.5. Johnson & Johnson. 100
18.6. Medtronic PLC 100
18.7. Teleflex Corporation. 100
18.8. Stryker Corporation. 100
18.9. B. Braun Melsungen AG.. 100
18.10. Abbott Laboratories. 100
18.11. Olympus Corporation. 100
18.12. Merit Medical Inc. 100
18.13. BD Company 100
Chapter No. 19 :…….. Research Methodology. 101
19.1. Research Methodology. 101
19.1.1. Phase I – Secondary Research. 102
19.1.2. Phase II – Data Modeling. 102
Company Share Analysis Model 103
Revenue Based Modeling. 103
19.1.3. Phase III – Primary Research. 104
19.1.4. Research Limitations. 105
Assumptions. 105
List of Figures
FIG NO. 1………. U.S. Guidewire Market Volume & Revenue, 2018 – 2032 (K Units) (USD Million) 25
FIG NO. 2………. Porter’s Five Forces Analysis for U.S. Guidewire Market. 33
FIG NO. 3………. Value Chain Analysis for U.S. Guidewire Market. 34
FIG NO. 4………. U.S. Guidewire Market Import Volume/Revenue, By Region, 2018 – 2023. 36
FIG NO. 5………. U.S. Guidewire Market Export Volume/Revenue, By Region, 2018 – 2023. 37
FIG NO. 6………. U.S. Guidewire Market Demand Volume/Revenue, By Region, 2018 – 2023. 38
FIG NO. 7………. U.S. Guidewire Market Supply Volume/Revenue, By Region, 2018 – 2023. 39
FIG NO. 8………. U.S. Guidewire Market Production Volume/Revenue, By Region, 2018 – 2023. 40
FIG NO. 9………. U.S. Guidewire Market Price, By Region, 2018 – 2023. 42
FIG NO. 10……… U.S. Guidewire Market Price, By Type, 2018 – 2023. 43
FIG NO. 11……… Raw Materials Price Trend Analysis, 2018 – 2023. 44
FIG NO. 12……… Manufacturing Cost Analysis. 45
FIG NO. 13……… Manufacturing Process. 45
FIG NO. 14……… Company Share Analysis, 2023. 46
FIG NO. 15……… Company Share Analysis, 2023. 47
FIG NO. 16……… Company Share Analysis, 2023. 47
FIG NO. 17……… Company Share Analysis, 2023. 47
FIG NO. 18……… Guidewire Market – Company Volume Market Share, 2023. 49
FIG NO. 19……… Guidewire Market – Company Revenue Market Share, 2023. 50
FIG NO. 20……… Guidewire Market Volume Share, By Type, 2023 & 2032. 56
FIG NO. 21……… Guidewire Market Revenue Share, By Type, 2023 & 2032. 56
FIG NO. 22……… Market Attractiveness Analysis, By Type. 57
FIG NO. 23……… Incremental Revenue Growth Opportunity by Type, 2024 – 2032. 57
FIG NO. 24……… Guidewire Market Revenue, By Type, 2018, 2023, 2027 & 2032. 58
FIG NO. 25……… U.S. Guidewire Market for Coronary, Volume & Revenue (K Units) (USD Million) 2018 – 2032. 59
FIG NO. 26……… U.S. Guidewire Market for Peripheral, Volume & Revenue (K Units) (USD Million) 2018 – 2032. 60
FIG NO. 27……… U.S. Guidewire Market for Urology, Volume & Revenue (K Units) (USD Million) 2018 – 2032. 61
FIG NO. 28……… U.S. Guidewire Market for Neurovascular, Volume & Revenue (K Units) (USD Million) 2018 – 2032. 62
FIG NO. 29……… U.S. Guidewire Market for Gastroenterology, Volume & Revenue (K Units) (USD Million) 2018 – 2032. 63
FIG NO. 30……… Guidewire Market Volume Share, By Application, 2023 & 2032. 65
FIG NO. 31……… Guidewire Market Revenue Share, By Application, 2023 & 2032. 65
FIG NO. 32……… Market Attractiveness Analysis, By Application. 66
FIG NO. 33……… Incremental Revenue Growth Opportunity by Application, 2024 – 2032. 66
FIG NO. 34……… Guidewire Market Revenue, By Application, 2018, 2023, 2027 & 2032. 67
FIG NO. 35……… U.S. Guidewire Market for Hydrophilic Surgical Guidewires, Volume & Revenue (K Units) (USD Million) 2018 – 2032. 68
FIG NO. 36……… U.S. Guidewire Market for Hydrophobic Surgical Guidewires, Volume & Revenue (K Units) (USD Million) 2018 – 2032. 69
FIG NO. 37……… U.S. Guidewire Market for Hydrophilic Diagnostic Guidewires, Volume & Revenue (K Units) (USD Million) 2018 – 2032. 70
FIG NO. 38……… U.S. Guidewire Market for Hydrophobic Diagnostic Guidewires, Volume & Revenue (K Units) (USD Million) 2018 – 2032. 71
FIG NO. 39……… U.S. Guidewire Market for Others, Volume & Revenue (K Units) (USD Million) 2018 – 2032. 72
FIG NO. 40……… Guidewire Market Volume Share, By End-user, 2023 & 2032. 74
FIG NO. 41……… Guidewire Market Revenue Share, By End-user, 2023 & 2032. 74
FIG NO. 42……… Market Attractiveness Analysis, By End-user. 75
FIG NO. 43……… Incremental Revenue Growth Opportunity by End-user, 2024 – 2032. 75
FIG NO. 44……… Guidewire Market Revenue, By End-user, 2018, 2023, 2027 & 2032. 76
FIG NO. 45……… U.S. Guidewire Market for Hospitals, Volume & Revenue (K Units) (USD Million) 2018 – 2032. 77
FIG NO. 46……… U.S. Guidewire Market for Ambulatory Surgical Centers, Volume & Revenue (K Units) (USD Million) 2018 – 2032. 78
FIG NO. 47……… U.S. Guidewire Market for Catheterization Laboratories, Volume & Revenue (K Units) (USD Million) 2018 – 2032. 79
FIG NO. 48……… U.S. Guidewire Market for Specialty Clinics, Volume & Revenue (K Units) (USD Million) 2018 – 2032. 80
FIG NO. 49……… U.S. Guidewire Market for Others, Volume & Revenue (K Units) (USD Million) 2018 – 2032. 81
FIG NO. 50……… Guidewire Market Volume Share, By Material, 2023 & 2032. 83
FIG NO. 51……… Guidewire Market Revenue Share, By Material, 2023 & 2032. 83
FIG NO. 52……… Market Attractiveness Analysis, By Material 84
FIG NO. 53……… Incremental Revenue Growth Opportunity by Material, 2024 – 2032. 84
FIG NO. 54……… Guidewire Market Revenue, By Material, 2018, 2023, 2027 & 2032. 85
FIG NO. 55……… U.S. Guidewire Market for Nitinol Guidewires, Volume & Revenue (K Units) (USD Million) 2018 – 2032. 86
FIG NO. 56……… U.S. Guidewire Market for Stainless Steel Guidewires, Volume & Revenue (K Units) (USD Million) 2018 – 2032. 87
FIG NO. 57……… U.S. Guidewire Market for Hybrid Guidewires, Volume & Revenue (K Units) (USD Million) 2018 – 2032. 88
FIG NO. 58……… U.S. Guidewire Market for PTFE Guidewires, Volume & Revenue (K Units) (USD Million) 2018 – 2032. 89
FIG NO. 59……… U.S. Guidewire Market for Others, Volume & Revenue (K Units) (USD Million) 2018 – 2032. 90
FIG NO. 60……… Guidewire Market Volume Share, By Tip Shape, 2023 & 2032. 92
FIG NO. 61……… Guidewire Market Revenue Share, By Tip Shape, 2023 & 2032. 92
FIG NO. 62……… Market Attractiveness Analysis, By Tip Shape. 93
FIG NO. 63……… Incremental Revenue Growth Opportunity by Tip Shape, 2024 – 2032. 93
FIG NO. 64……… Guidewire Market Revenue, By Tip Shape, 2018, 2023, 2027 & 2032. 94
FIG NO. 65……… U.S. Guidewire Market for J Tip, Volume & Revenue (K Units) (USD Million) 2018 – 2032. 95
FIG NO. 66……… U.S. Guidewire Market for Angled Tip, Volume & Revenue (K Units) (USD Million) 2018 – 2032. 96
FIG NO. 67……… U.S. Guidewire Market for Straight Tip, Volume & Revenue (K Units) (USD Million) 2018 – 2032. 97
FIG NO. 68……… Research Methodology – Detailed View.. 101
FIG NO. 69……… Research Methodology. 102
List of Tables
TABLE NO. 1. :…. U.S. Guidewire Market: Snapshot 20
TABLE NO. 2. :…. Drivers for the Guidewire Market: Impact Analysis. 26
TABLE NO. 3. :…. Restraints for the Guidewire Market: Impact Analysis. 28
TABLE NO. 4. :…. U.S. Guidewire Market Production Volume, By Region, 2018 – 2023 (K Units) 38
TABLE NO. 5. :…. U.S. Guidewire Market Volume & Revenue, By Region, 2018 – 2023. 39
TABLE NO. 6. :…. U.S. Guidewire Market Volume & Revenue, By Type, 2018 – 2023. 40
TABLE NO. 7. :…. Key Raw Materials & Suppliers. 41
Request A Free Sample
We prioritize the confidentiality and security of your data. Our promise: your information remains private.
Ready to Transform Data into Decisions?
Request Your Sample Report and Start Your Journey of Informed Choices
Providing the strategic compass for industry titans.
About Author
Shweta Bisht
Healthcare & Biotech Analyst
Shweta is a healthcare and biotech researcher with strong analytical skills in chemical and agri domains.
Related Reports
Chimeric Antigen Receptor Macrophage Immunotherapy Market
Chimeric Antigen Receptor Macrophage Immunotherapy Market size was valued USD 373.5 million in 2024 and is anticipated to reach USD 590.82 million by 2032, at a CAGR of 5.9% during the forecast period.
Posture Correction Market
The Posture Correction Market is projected to grow from USD 1.66 billion in 2024 to an estimated USD 2.76 billion by 2032, with a CAGR of 6.5% from 2024 to 2032.
Postpartum Health Supplements Market
The Postpartum Health Supplements Market is projected to grow from USD 1,366.02 million in 2024 to an estimated USD 2,701.98 million by 2032, at a CAGR of 8.9% from 2024 to 2032.
Drug Discovery And Development Laboratory Services Market
Drug Discovery And Development Laboratory Services Market size was valued at USD 14,768 million in 2024 and is anticipated to reach USD 32,825.39 million by 2032, expanding at a CAGR of 10.5% during the forecast period.
Diabetic Retinopathy Market
Diabetic Retinopathy market size was valued at USD 9,598 Million in 2024 and is anticipated to reach USD 15,553.28 Million by 2032, growing at a CAGR of 6.22% during the forecast period.
Autoinjectors Market
Autoinjectors Market size was valued USD 63708 million in 2024 and is anticipated to reach USD 252769.2 million by 2032, at a CAGR of 18.8% during the forecast period.
Asia Pacific Oral Solid Dosage Contract Manufacturing Market
Asia Pacific Oral Solid Dosage Contract Manufacturing Market size was valued USD 11710 million in 2024 and is anticipated to reach USD 20225.69 million by 2032, at a CAGR of 7.07% during the forecast period.
Anaplastic Astrocytoma Market
Anaplastic Astrocytoma Market size was valued USD 1658 million in 2024 and is anticipated to reach USD 3000.94 million by 2032, at a CAGR of 7.7% during the forecast period.
Adult Neurosurgery Devices Market
Adult Neurosurgery Devices Market size was valued at USD 10.48 Billion in 2024 and is anticipated to reach USD 15.37 Billion by 2032, growing at a CAGR of 4.9% during the forecast period.
Antitussives Market
Global Antitussives market size was valued at USD 1,415.4 million in 2018 to USD 1,936.8 million in 2024 and is anticipated to reach USD 3,138.2 million by 2032, at a CAGR of 6.29% during the forecast period.
Goodpasture Syndrome Treatment Market
Goodpasture Syndrome Treatment Market was valued at USD 437.6 million in 2024 and is anticipated to reach USD 1106.92 million by 2032, growing at a CAGR of 12.3% during the forecast period.
Pompe Disease Treatment Market
The Pompe Disease Treatment Market is projected to grow from USD 1057.6 million in 2024 to an estimated USD 1265.63 million by 2032, with a CAGR of 2.27% from 2024 to 2032.
Licence Option
The report comes as a view-only PDF document, optimized for individual clients. This version is recommended for personal digital use and does not allow printing. Use restricted to one purchaser only.
$2999
To meet the needs of modern corporate teams, our report comes in two formats: a printable PDF and a data-rich Excel sheet. This package is optimized for internal analysis. Unlimited users allowed within one corporate location (e.g., regional office).
$4999
The report will be delivered in printable PDF format along with the report’s data Excel sheet. This license offers 100 Free Analyst hours where the client can utilize Credence Research Inc. research team. Permitted for unlimited global use by all users within the purchasing corporation, such as all employees of a single company.
$8999
Report delivery within 24 to 48 hours
Quick Connect
Europe
North America
Request A Free Sample
What people say?
Thank you for the data! The numbers are exactly what we asked for and what we need to build our business case.
Materials Scientist
(privacy requested)
The report was an excellent overview of the Industrial Burners market. This report does a great job of breaking everything down into manageable chunks.
Imre Hof
Management Assistant, Bekaert
Trusted By